QUADRACEL
QUADRACEL
Discontinued
DIN Number
02230946
Drug Class
Human
Market Date
Jun 20, 1997
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230946
AIG Number0933021001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07CA02 DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (9)
DIPHTHERIA TOXOIDActive
Strength: 15 LF / 0.5 ML
Monograph: DIPHTHERIA TOXOID
FILAMENTOUS HAEMAGGLUTININActive
Strength: 20 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ
FIMBRIAEActive
Strength: 5 MCG / 0.5 ML
Monograph: FIMBRIAE
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEYActive
Strength: 40 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1Active
Strength: 8 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETTActive
Strength: 32 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT
PERTACTINActive
Strength: 3 MCG / 0.5 ML
Monograph: PERTACTIN
PERTUSSIS TOXOIDActive
Strength: 20 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID
TETANUS TOXOIDActive
Strength: 5 LF / 0.5 ML
Monograph: TETANUS TOXOID